| protein methylation | GO:0006479 | 81 | 0.433 | |
| oocyte axis specification | GO:0007309 | 2 | 0.294 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.249 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.236 | |
| chromatin organization | GO:0006325 | 206 | 0.195 | |
| histone lysine methylation | GO:0034968 | 50 | 0.184 | |
| pole plasm assembly | GO:0007315 | 2 | 0.168 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.150 | |
| germ cell development | GO:0007281 | 185 | 0.145 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.138 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.131 | |
| protein ubiquitination | GO:0016567 | 171 | 0.128 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.127 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.124 | |
| macromolecule methylation | GO:0043414 | 120 | 0.120 | |
| oocyte construction | GO:0007308 | 2 | 0.118 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.114 | |
| protein catabolic process | GO:0030163 | 221 | 0.114 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.091 | |
| chromatin modification | GO:0016568 | 187 | 0.088 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.086 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.084 | |
| rhythmic process | GO:0048511 | 174 | 0.080 | |
| oocyte differentiation | GO:0009994 | 35 | 0.079 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.074 | |
| regionalization | GO:0003002 | 337 | 0.072 | |
| organelle fission | GO:0048285 | 170 | 0.069 | |
| protein alkylation | GO:0008213 | 81 | 0.065 | |
| nuclear division | GO:0000280 | 158 | 0.064 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.063 | |
| gonad development | GO:0008406 | 141 | 0.060 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.060 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.059 | |
| rna processing | GO:0006396 | 105 | 0.057 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.056 | |
| methylation | GO:0032259 | 134 | 0.056 | |
| mrna metabolic process | GO:0016071 | 84 | 0.053 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.051 | |
| histone methylation | GO:0016571 | 71 | 0.051 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.048 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.048 | |
| gland development | GO:0048732 | 330 | 0.045 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.045 | |
| gene silencing | GO:0016458 | 38 | 0.040 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.039 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.039 | |
| stem cell proliferation | GO:0072089 | 117 | 0.039 | |
| mrna processing | GO:0006397 | 63 | 0.039 | |
| protein acylation | GO:0043543 | 64 | 0.038 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.038 | |
| histone acetylation | GO:0016573 | 41 | 0.037 | |
| oogenesis | GO:0048477 | 56 | 0.037 | |
| female sex differentiation | GO:0046660 | 84 | 0.036 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.034 | |
| axonogenesis | GO:0007409 | 274 | 0.033 | |
| translation | GO:0006412 | 93 | 0.032 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.031 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.031 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.031 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.031 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.031 | |
| rna splicing | GO:0008380 | 54 | 0.030 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.030 | |
| male gamete generation | GO:0048232 | 285 | 0.029 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.029 | |
| learning or memory | GO:0007611 | 148 | 0.028 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.028 | |
| cell maturation | GO:0048469 | 127 | 0.028 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.027 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.027 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.026 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.026 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.025 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.025 | |
| spermatogenesis | GO:0007283 | 284 | 0.025 | |
| ovulation cycle | GO:0042698 | 59 | 0.025 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.024 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.024 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.024 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.024 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.024 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.023 | |
| male meiosis | GO:0007140 | 37 | 0.023 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.023 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.023 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.023 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.023 | |
| female gamete generation | GO:0007292 | 74 | 0.023 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.022 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.022 | |
| histone modification | GO:0016570 | 159 | 0.022 | |
| meiosis i | GO:0007127 | 60 | 0.022 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.022 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.022 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.021 | |
| b cell activation | GO:0042113 | 161 | 0.021 | |
| regulation of neuron death | GO:1901214 | 134 | 0.021 | |
| glucose homeostasis | GO:0042593 | 128 | 0.021 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.021 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.021 | |
| memory | GO:0007613 | 58 | 0.021 | |
| tube formation | GO:0035148 | 140 | 0.020 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.020 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.020 | |
| dna alkylation | GO:0006305 | 43 | 0.020 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.020 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.020 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.019 | |
| developmental maturation | GO:0021700 | 193 | 0.019 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.019 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.019 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.019 | |
| protein localization to organelle | GO:0033365 | 185 | 0.019 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.019 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.019 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.019 | |
| circadian rhythm | GO:0007623 | 114 | 0.018 | |
| spermatid development | GO:0007286 | 108 | 0.018 | |
| camera type eye development | GO:0043010 | 266 | 0.018 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.018 | |
| oocyte development | GO:0048599 | 33 | 0.017 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.017 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.017 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.017 | |
| neuron death | GO:0070997 | 154 | 0.017 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.017 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.017 | |
| cognition | GO:0050890 | 149 | 0.016 | |
| stem cell differentiation | GO:0048863 | 268 | 0.016 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.016 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.016 | |
| regulation of dna templated transcription elongation | GO:0032784 | 10 | 0.016 | |
| chemotaxis | GO:0006935 | 247 | 0.016 | |
| regulation of response to drug | GO:2001023 | 2 | 0.016 | |
| protein maturation | GO:0051604 | 176 | 0.016 | |
| nuclear transport | GO:0051169 | 139 | 0.015 | |
| microtubule based process | GO:0007017 | 236 | 0.015 | |
| gene silencing by rna | GO:0031047 | 19 | 0.015 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.015 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.015 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.015 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.015 | |
| rna interference | GO:0016246 | 2 | 0.015 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.015 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.015 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.014 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.014 | |
| cellularization | GO:0007349 | 1 | 0.014 | |
| bone development | GO:0060348 | 120 | 0.014 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.014 | |
| epithelial tube formation | GO:0072175 | 130 | 0.014 | |
| stem cell development | GO:0048864 | 219 | 0.014 | |
| regulation of translation | GO:0006417 | 71 | 0.014 | |
| endocytosis | GO:0006897 | 168 | 0.014 | |
| protein processing | GO:0016485 | 163 | 0.014 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.013 | |
| organelle assembly | GO:0070925 | 177 | 0.013 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.013 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.013 | |
| axon guidance | GO:0007411 | 141 | 0.013 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.013 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.013 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.013 | |
| neuron projection guidance | GO:0097485 | 141 | 0.013 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.013 | |
| regulation of system process | GO:0044057 | 200 | 0.013 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.013 | |
| negative regulation of cellular protein catabolic process | GO:1903363 | 22 | 0.013 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.013 | |
| chromatin remodeling | GO:0006338 | 32 | 0.013 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.013 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.013 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.013 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.012 | |
| regulation of synapse structural plasticity | GO:0051823 | 4 | 0.012 | |
| regulation of histone modification | GO:0031056 | 56 | 0.012 | |
| protein polyubiquitination | GO:0000209 | 33 | 0.012 | |
| positive regulation of hormone metabolic process | GO:0032352 | 3 | 0.012 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.012 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.012 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.012 | |
| defense response to other organism | GO:0098542 | 197 | 0.012 | |
| mesenchyme development | GO:0060485 | 152 | 0.012 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.012 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.012 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.012 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.012 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.012 | |
| segmentation | GO:0035282 | 93 | 0.012 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.012 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.012 | |
| negative regulation of histone h3 k9 methylation | GO:0051573 | 4 | 0.012 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.012 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.012 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.012 | |
| response to uv | GO:0009411 | 44 | 0.012 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.012 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.012 | |
| compound eye development | GO:0048749 | 1 | 0.011 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.011 | |
| urogenital system development | GO:0001655 | 261 | 0.011 | |
| cell division | GO:0051301 | 120 | 0.011 | |
| regulation of secretion | GO:0051046 | 274 | 0.011 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.011 | |
| cell recognition | GO:0008037 | 83 | 0.011 | |
| ovarian follicle development | GO:0001541 | 40 | 0.011 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.011 | |
| nuclear import | GO:0051170 | 95 | 0.011 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.011 | |
| leydig cell differentiation | GO:0033327 | 10 | 0.011 | |
| steroid metabolic process | GO:0008202 | 119 | 0.011 | |
| dna repair | GO:0006281 | 107 | 0.011 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.011 | |
| neuroblast proliferation | GO:0007405 | 49 | 0.011 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.011 | |
| heterochromatin organization | GO:0070828 | 4 | 0.011 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.011 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.011 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.011 | |
| dephosphorylation | GO:0016311 | 129 | 0.011 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.011 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.011 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.011 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.011 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.011 | |
| habituation | GO:0046959 | 3 | 0.011 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.011 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.011 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.011 | |
| response to growth factor | GO:0070848 | 198 | 0.011 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.011 | |
| cell fate commitment | GO:0045165 | 210 | 0.011 | |
| cytokine production | GO:0001816 | 319 | 0.011 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.011 | |
| neural tube formation | GO:0001841 | 108 | 0.011 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.011 | |
| positive regulation of antimicrobial peptide production | GO:0002225 | 1 | 0.010 | |
| skeletal system development | GO:0001501 | 356 | 0.010 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.010 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.010 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.010 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.010 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.010 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.010 | |
| neuronal action potential | GO:0019228 | 54 | 0.010 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.010 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.010 | |
| lateral inhibition | GO:0046331 | 1 | 0.010 | |
| ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway | GO:0043162 | 3 | 0.010 | |
